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Abstract: There is now considerable scientific evidence that a diet rich in fruits and 
vegetables can improve human health and protect against chronic diseases. However, it is 
not clear whether different fruits and vegetables have distinct beneficial effects. Apples are 
among the most frequently consumed fruits and a rich source of polyphenols and fiber. A 
major proportion of the bioactive components in apples, including the high molecular 
weight polyphenols, escape absorption in the upper gastrointestinal tract and reach the 
large intestine relatively intact. There, they can be converted by the colonic microbiota to 
bioavailable and biologically active compounds with systemic effects, in addition to 
modulating microbial composition. Epidemiological studies have identified associations 
between frequent apple consumption and reduced risk of chronic diseases such as 
cardiovascular disease. Human and animal intervention studies demonstrate beneficial 
effects on lipid metabolism, vascular function and inflammation but only a few studies 
have attempted to link these mechanistically with the gut microbiota. This review will 
focus on the reciprocal interaction between apple components and the gut microbiota, the 
potential link to cardiovascular health and the possible mechanisms of action. 
Keywords: apples; juice; fiber; pectin; polyphenols; cardiovascular; gut microbiota; blood 
lipid; cholesterol; vascular; inflammation  
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1. Introduction 
A high intake of plant derived foods such as fruits, vegetables and whole grains can have a 
preventative effect against cardiovascular diseases (CVD) [1–3]. The mechanisms are not entirely clear 
but plant polyphenols and fiber are considered the principal mediators. Apples are among the most 
popular and frequently consumed fruits in the world, because of their availability throughout the year, 
in a variety of forms including fresh fruit, juice, cider, concentrate and puree [4], and the general 
perception that apples are good for health [5]. Epidemiological studies support the view that frequent 
apple consumption is associated with a reduced risk of chronic pathologies such as cardiovascular 
disease, specific cancers, and diabetes [6–10]. Data from intervention studies in humans and animals 
suggest that apple intake may positively affect lipid metabolism [11–15], weight management [16], 
vascular function [17,18] and inflammation [19–22]. Apples are a rich source of polyphenols and fiber. 
The main polyphenol classes in increasing order are: Dihydrochalcones, flavonols, hydroxycinnamates 
and flavanols (catechin and proanthocyanidins (PAs)) [23]. Readily absorbed polyphenols such as 
flavanol monomers may be responsible for some of the health effects. However, larger polyphenol 
molecules such as the PAs, a major class of apple polyphenols, together with pectin, the main soluble 
fiber in apples and other cell wall components, reach the colon and undergo extensive bioconversion 
by colonic microbiota producing metabolites that may have local intestinal effects whilst in the gut, 
and systemic effects after absorption. Apple polyphenols and fiber may also beneficially modulate the 
gut microbiota composition and activity [24–27]. The gut microbiota may serve as a potential novel 
target for the prevention of CVD [28]. 
In this review we will present the major apple components and their reciprocal interaction with the 
gut microbiota; the evidence relating to the ability of apples to reduce CVD risk from in vitro and  
in vivo studies in animals and humans focusing on lipid metabolism, vascular function, blood pressure 
and inflammation; and finally the possible mechanisms which link the human gut microbiota and gut 
function to reduced risk.  
2. Apple Components 
Apples are low in fat and high in carbohydrate, with fructose as the predominant sugar. Apples are 
also a rich source of vitamins (mainly C and E), minerals (potassium and magnesium), triterpenoids, 
such as ursolic acid, fiber (soluble and insoluble) and polyphenols (Table 1).  
Table 1. Composition of apples (Malus domestica), raw with skin. USDA National 
Nutrient Database for Standard Reference.  
Components Value per 100 g 
Energy (kcal) 52 
Energy (kJ) 218 
Water (g) 85.56 
Total carbohydrates (g) 13.81 
§ Total dietary fiber (g) 2.21 
§ Insoluble fiber (g) 1.54 
§ Soluble fiber (g) 0.67 
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Table 1. Cont. 
Total sugars (g) 10.39 
Fructose (g) 5.9 
Glucose (dextrose) (g) 2.43 
Sucrose (g) 2.07 
Starch (g) 0.05 
Protein (g)  0.26 
Total lipid (fat) (g) 0.17 
Fatty acids, total polyunsaturated (g) 0.051 
Fatty acids, total monounsaturated (g) 0.007 
Fatty acids, total saturated (g) 0.028 
Vitamin C, total ascorbic acid (mg) 4.6 
Thiamin (mg) 0.017 
Riboflavin (mg) 0.026 
Niacin (mg) 0.091 
Vitamin B-6 (mg) 0.041 
Folate, DFE (μg) 3 
Vitamin A, RAE (μg) 3 
Vitamin A, IU (IU) 54 
Vitamin E (alpha-tocopherol) (mg) 0.18 
Vitamin K (phylloquinone) (μg) 2.2 
Calcium, Ca (mg) 6 
Iron, Fe (mg) 0.12 
Magnesium, Mg (mg) 5 
Phosphorus, P (mg) 11 
Potassium, K (mg) 107 
Sodium, Na (mg) 1 
Zinc, Zn (mg) 0.04 
* Total polyphenols (mg) 110.20 
* Flavanols (mg) 96.33 
* Hydroxycinnamates (mg) 14.21 
* Flavonols (mg) 5.66 
* Dihydrochalcones (mg) 4.17 
# Anthocyanins (mg) 1.62 
§ Data from Li et al., 2002 [29]; * data from Vrhovsek et al., 2004 [23]; # only in red apples. 
2.1. Apple Fiber 
Apples contain approximately 2%–3% fiber [29,30]. They are rich in insoluble fiber, including 
cellulose and hemicullose, with pectin as the major soluble fiber containing homogalacturonans 
(consisting of long chains of α-(1–4) linked galacturonic acids) and rhamnogalacturonans. The degree 
of methylation, DM (or degree of esterification), of the galacturonic acid residues strongly influence 
the functional and physicochemical properties [31–33]. It has been reported that apple pectin has 
cholesterol lowering properties [34] and beneficial effects on glucose metabolism [35]. The structural 
parameters of pectin, including molecular weight and DM, have a major influence on the degree of 
these effects [32,34,36,37]. Moreover, pectin is a gelling agent and impacts on transit time, gastric 
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emptying and nutrient absorption from the gut [34,38–41]. It is resistant to degradation by gastric acid 
and intestinal enzymes and thus, reaches the colon where it is fermented by the gut microbiota into 
short chain fatty acids (SCFA) [26,42–44].  
2.2. Apple Polyphenols  
The polyphenol content of apples has been extensively measured in various studies [4,23,45–47] 
with only the most recent including the determination of oligomeric and polymeric PAs (representing 
approximately 80% of apple polyphenols) [4,23]. PAs, also known as condensed tannins, are 
oligomers and polymers of flavanols and are composed mainly of (−)-epicatechin units, although some 
of the terminal units may be from (+)-catechin. The most common subclass of PAs is the procyanidins 
(PCs) consisting of (epi)catechin units [48]. Vrhovsek et al. (2004) reported the polyphenol content in 
apples representing 8 of the most widely cultivated varieties in south and west Europe [23]. The mean 
concentration of total polyphenols was 110.2 mg/100 g of fresh fruit and ranged from 66.2 mg to  
211.9 mg/100 g according to the following increasing order: Fuji, Braeburn, Royal Gala, Golden 
Delicious, Morgenduft, Granny Smith, Red Delicious and Renetta [23]. Flavanols (catechin and PAs) 
was the major class of apple polyphenols (71%–90%), followed by hydroxycinnamates (4%–18%), 
flavonols (1%–11%), dihydrochalcones (2%–6%) and anthocyanins (1%–3%), only in red apples [23]. 
Similarly a later study by Wojdylo et al. (2008) on 67 old and new varieties grown in Western Europe 
reported, flavanols (catechin and oligomeric PCs), 80%, hydroxycinnamic acids, 1%–31%, flavonols, 
2%–10%, dihydrochalcones, 0.5%–5% and in red apples, anthocyanins, 1% [4]. The polyphenol 
profiles among several varieties are similar, but the concentration range varies [45,49–52] due to 
differences in cultivars, growing conditions (light availability), maturity, storage, extraction 
procedures, analytical techniques and pre- or post-harvest factors [47].  
Phenolic compounds in apples are not evenly distributed in the fruit tissue. Despite the small 
contribution of apple peel (6%–8%) to whole fruit weight [53], peel contains a significantly higher 
content of phenolics. In particular all the flavonols (quercetin conjugates) and anthocyanins, as well as 
an important part of dihydrochalcones (phloridzin and phloretin glycosides) [23,46]. Moreover, the 
peel contains large amounts of PCs, (−)-epicatechin, (+)-catechin which also appear in the flesh but in 
lower concentrations [54]. Flesh has higher chlorogenic and some dihydrochoalcones [54]. The high 
content of polyphenols in the peel has been attributed to their defensive role against pathogens which 
may protect the fruit [55]. Apple juice contains only small amounts of quercetin glycosides and 
dihydrochalcones. Moreover, the technological processing is crucial. Clear apple juice has a small 
polyphenol content due to the oxidative conditions during the pulping and pressing and the final 
clarification process [56]. Cloudy apple juice on the other hand may maintain an important polyphenol 
amount due to anaerobic conditions and the lack of the clarification step [56,57]. 
2.2.1. Absorption and Bioavailability of Apple Polyphenols 
The health effects of polyphenols are likely to depend upon the initial dose, absorption and 
bioavailability [58]. The absorption of polyphenols is influenced by various factors such as their 
physicochemical properties (e.g., molecular size, degree of polymerization (DP), solubility, pKa), 
biological factors (through their passage in the gastrointestinal tract), food matrix, interaction with 
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other dietary components and gut microbiota composition [59,60]. Aglycones and a few glycosides, 
mainly the low molecular weight polyphenols, can be directly absorbed in the small intestine [61]. 
High molecular weight polyphenols such as polymeric PAs reach the colon almost unchanged 
where they are transformed by the intense metabolic activity of the gut microbiota, a requirement for 
their absorption [61]. Glycosylated polyphenols require loss of their sugar moiety and esterified 
phenolic acids are hydrolyzed. In the brush borders of the intestine and after absorption in the liver, 
polyphenols undergo phase II metabolism leading to the formation of glucuronides, sulphates or 
methylated derivatives [61]. An increasing evidence base indicates that the concentration of parent 
polyphenols in human plasma is lower, sometimes by several orders of magnitude, than the 
concentration of pure polyphenols or plant extracts observed to have potential health effects  
in vitro. [59,61]. Moreover, bioconverted and conjugated forms of intact polyphenols could have 
higher biological activity than their parent compounds [61]. Absorbed polyphenols can either circulate 
in the blood reaching the target tissues or be resecreted into the intestine via the bile as a result of the 
enterohepatic circulation. The latter fraction can be either deconjugated by gut microbes and absorbed, 
or further metabolized by the gut microbiota [59,61,62]. A detailed review of the bioavailability and 
metabolism of the apple derived polyphenols in humans is presented by Bergmann et al. [63].  
PCs are the major polyphenols in apples and cloudy apple juice, with only the monomeric, and to a 
lesser extent dimeric fractions, readily absorbed [64,65]. Oligomeric PCs may be cleaved into smaller 
units during their passage through the gastrointestinal tract, however, the major fraction (90%) is not 
absorbed and thus, reaches the colon [66]. Both in vitro and animal studies support the theory that a 
high polymerization decreases intestinal absorption [67]. Fifty-eight percent of polyphenols present in 
cloudy apple juice were absorbed or degraded, with the remaining detected in the ileostomy fluid [66].  
Hydroxycinnamic acids are also an important group of polyphenols in apple products. In a study by 
Hagl et al. (2011), 10 healthy ileostomy subjects consumed 0.7 L of apple smoothie containing 60% of 
cloudy apple juice and 40% apple puree [60]. After 8 hours, 63% of the total polyphenols and  
D-(–)-quinic acid were found in the ileostomy bags compared with 60.9% of the hydroxycinnamic 
acids [60] with only 28.1% of hydroxycinnamic acids from pure cloudy apple juice [66]. Differences 
in the amount consumed and the quantity of cell wall compounds in apple smoothie may be 
responsible for the inconsistent results [60,66]. Hydroxycinnamic acids, including caffeoylquinic acids 
and p-coumaroylquinic acids, may be metabolized or hydrolyzed in the small intestine leading to  
D-(−)-quinic acid and caffeic or p-coumaric liberation which can be absorbed [60,66]. However, a 
significant proportion of chlorogenic acid (5-caffeoylquinic acid), may reach the colon where it can be 
further metabolized by the gut microbiota [59,60,67,68].  
It has been reported that quercetin from apples is less bioavailable than that found in onions, due to 
differences in the quercetin conjugates present [69], suggesting that the sugar moiety affects  
absorption. [67]. Quercetin aglycones and glucosides, present in onions, are more bioavailable 
compared to quercetin monoglycosides and quercetin rutinosides found in apples [69,70]. Other 
studies reported that quercetin glucosides were more effectively absorbed compared to pure  
quercetin [67]. The main quercetin glycosides detected in human ileostomy bags after the consumption 
of apple smoothie or cloudy apple juice were 3-O-rhamnoside and 3-O-arabinoside, with higher 
recovery rates after apple smoothie consumption (46.3%) [60] compared with the cloudy apple juice 
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(2.9%) [66]. In the large intestine, microorganisms can cleave the glycosidic bonds and free quercetin 
which can be absorbed or further metabolized by the gut microbiota [71].  
The main dihydrochalcones include phloretin 2′-O-glucoside and phloretin-2′-O-(2′′-O-xylosyl) 
glucoside and are characteristic ingredients of apples and apple products. In a human study by Marks  
et al. (2009) the absorption and metabolism of the major apple dihydrochalones were explored in  
9 healthy and 5 ileostomy subjects after the consumption of 500 ml of apple cider [72]. Phloretin 
glycosides were metabolized to phloretin 2´-O-glucuronide in both the healthy and ileostomy 
volunteers. Moreover, phloretin-2′-O-(2′′-O-xylosyl) glucoside was present in the ileal fluid together 
with the aglycone phloretin, two phloretin-O-glucuronides, and two phloretin-O-sulfates, but none of 
the ingested phloretin 2′-O-glucoside [72]. In total, 38.6% of the total dihydrochalcones were detected 
in the ileal fluid. These findings are consistent with Kahle et al. (2007) and Hagl et al. (2011) [60,66].  
3. The Human Gut Microbiota—Effects of Fiber and Polyphenols  
The human gut is host to a diverse collection of microorganisms, comprising approximately  
1012 microbial cells per gram of gut content and up to 1000 different species [73,74]. This collection of 
microorganisms is called the gut microbiota. The human colon is dominated mainly by two phyla, the 
Firmicutes and Bacteroidetes, representing more than 90% of all the phylotypes, followed by lower 
relative abundances of Actinobacteria, Proteobacteria, Fusobacteria and Verrucomicrobia [75]. The gut 
microbiota plays an important role in human health by increasing the efficiency of ‘energy harvest’ 
from the diet through the metabolism of nondigestible dietary components, maintaining immune 
homeostasis, synthesizing vitamins, such as B12 and K, providing a barrier to invading pathogenic 
microorganisms and reinforcing the intestinal epithelial cell tight junctions [76]. Bifidobacteria, 
lactobacilli and butyrate producing bacteria, such as Faecalibacterium prausnitzii and Eubacterium 
rectale, are commonly considered as health promoting bacteria involved in saccharolytic fermentation 
producing SCFA [75,76]. In contrast the overgrowth of other bacteria, such as the Enterobacteriaceae 
and certain clostridia groups, is associated with negative health implications. Aberrant gut microbiota 
composition has been associated with metabolic diseases including obesity, type I and type II diabetes 
and atherosclerosis, certain cancers and autoimmune diseases [77–79]. It has been shown that obese 
people have an increase ratio of Firmicutes/Bacteroidetes compared to lean subjects [80], however, 
this was not confirmed by later studies [81,82]. More recently it has been suggested that differences in 
microbiota diversity may be more important, in these pathologies, than changes in specific bacteria 
populations [83]. 
Gut microbiota profiles can be modified through diet [79,80,84]. The type and quantity of food 
components that reach the colon have an important impact on microbiota composition and  
activity [85]. Dietary fiber, a major substrate for colonic fermentation, plays an important role  
against the development of chronic diseases such as type 2 diabetes, heart disease, obesity and  
cancers [86–89]. This is particularly true for prebiotic fiber, a term first introduced in the mid-1990s 
referring to a class of fiber that may beneficially alter the colonic microbiota [90]. According to the 
recent definition by Gibson et al. (2010), a dietary prebiotic is ‘‘a selectively fermented ingredient that 
results in specific changes in the composition and/or activity of the gastrointestinal microbiota, thus 
conferring benefit(s) to host health’’ [91]. Well established prebiotics include inulin, 
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fructooligosaccharides, galactooligosaccharides and lactulose, which have been consistently reported 
to increase relative numbers of bifidobacteria and lactobacilli [91]. Moreover, fiber is the main energy 
source for the gut microbiota leading to production of SCFAs butyrate, acetate and propionate [85]. 
These organic acids have multiple functions in the host, as key energy sources for intestinal mucosa, 
liver, muscle or other peripheral tissues contributing about 7%–8% of daily energy requirements. But 
more importantly they play a significant role in cell function, immune system, lipid metabolism, gut 
motility and permeability, affecting the risk of gastrointestinal disorders, cancers and CVD [85,92,93].  
Moreover, up to 90% of dietary plant polyphenols [94] including apples, reach the colon  
intact [48,59,95,96]. The interaction with the gut microbiota is reciprocal, since commensal bacteria 
transform polyphenols into simple aromatic metabolites while polyphenols have the ability to 
modulate the gut microbiota composition, inhibiting some bacterial populations and stimulating  
others [97,98]. Tzounis et al. (2011) showed that a high cocoa flavanol drink (494 mg/day) 
significantly increased fecal bifidobacteria and lactobacilli, but decreased clostridia populations after  
4 weeks, compared with a low cocoa flavanol drink (23 mg/day), in a randomized, double-blind, 
controlled, crossover, human intervention trial of 22 subjects [99]. Similar prebiotic effects have been 
shown in a study exploring the impact of red wine, dealcoholized red wine and gin consumption on gut 
microbiota composition in 10 subjects for 20 days [100]. The intake of red wine increased the number 
of Enterococcus, Bacteroides, and Prevotella genera and decreased the Clostridium genera and 
Clostridium histolyticum group [100]. These effects were not observed after the gin consumption, used 
as an alcohol control, which gave significant increased levels of fecal clostridia and Bacteroides, and 
decreased Prevotellaceae [100]. Both red wine and dealcoholized red wine increased the levels of 
Blautia coccoides–Eubacterium rectale group, Bifidobacterium, Eggerthella lenta, and Bacteroides 
uniformis, indicating the beneficial effects of wine polyphenols [100]. Finally, the beneficial observed 
reductions in total cholesterol (TC) and C-reactive protein (CRP) were related to the changes in 
bifidobacteria number [100]. However, these beneficial effects on gut health were not confirmed in a 
recent placebo-controlled, crossover, human intervention study by Wallace et al. (2015), where a 
boysenberry beverage (750 mg polyphenols, anthocyanins and ellagitannis/ellagic acid as the main 
source) and an apple fiber beverage (7.5 g) were consumed separately and in combination [101].  
There was no indication of significant differences in fecal bacteria or SCFA levels after 4 weeks  
intervention [101]. Differences in polyphenol dose, class and the food matrix is a crucial factor to 
consider when interpreting these results. The modulation of gut microbiota activity and composition by 
apple components has been shown in in vitro and in vivo experiments, the majority in animals and only 
a few in humans.  
3.1. Impact of Apple Components on the Gut Microbiota Composition 
3.1.1. In vitro Studies 
Pectin is almost completely fermented in vitro and thus, can modify the human gut microbiota 
composition [42–44]. Structural characteristics such as DM and molecular weight influence the 
fermentability properties [31,33,102]. The speed of fermentation and selectivity by the human fecal 
bacteria for low and high methylated pectins are inconsistent in different studies which may be due to 
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variability in the fecal donor and in vitro experimental conditions [31,33,102]. Furthermore it was 
reported that pectin fermentation was relatively common among Bacteroides spp. and only performed 
by Eubacterium eligens among gram-positive anaerobes including species from Firmicutes and 
actinobacteria [103,104]. Later studies show that Faecalibacterium prausnitzii, which belongs to the 
Firmicutes, are able to utilize apple pectin and compete with known pectin utilizing species such as 
Bacteroides thetaiotaomicron and Eubacterium eligens [105]. However, the fermentability of pectic 
oligosaccharides (POS) differs from pectin. Comparing the two substrates Olano-Martin et al. (2002) 
showed that POS increased bifidobacteria number whereas pectin increased Bacteroides and  
Clostridium [102]. Similarly, it has been shown that apple POS increased bifidobacteria and 
lactobacilli levels and decreased clostridia and Bacteroides, while pectin increased bifidobacteria, 
clostridia, Bacteroides and eubacteria [106]. Thus, these studies indicate that selectivity towards 
bifidobacteria may only be confirmed for POS, suggesting a prebiotic effect.  
The effects of pure apple PAs on the gut microbiota composition are not well explored. In an  
in vitro batch culture system, inoculated with human faeces, a decrease in SCFA concentration after 
apple PAs fermentation was reported, suggesting reduction of beneficial saccharolytic fermentation, 
although, the specific bacteria composition was not determined [107]. It has been shown that PAs 
possess antimicrobial properties by inhibiting microbial enzymes [108], binding to bacterial cells 
affecting membrane function [109] and complex formation with metal ions, including iron, affecting 
bacterial growth [110]. Although there is evidence of a bacteriostatic effect of condensed tannins this 
inhibition may be selective to particular bacterial species. Animal studies using flavanols from 
blackcurrant extract, grape pomace or tannin rich diets modified the balance of gut microbiota 
composition towards beneficial bacteria [111–113]. Moreover, it has been suggested that structural 
differences of the bacterial cell walls and membranes may explain why gram-positive bacteria such as 
clostridia are more sensitive to bactericidal effects of tannins compared to gram-negative Prevotella 
and Bacteroides species [111]. 
3.1.2. Animal Studies 
Short and long term consumption of whole apples and apple components modified the rat caecal 
microbiota composition [26]. Pectin was considered as the main bioactive component after 
administration of 7% of apple pectin for 4 weeks by increasing Clostridium coccoides populations and 
the expression of genes encoding the butyryl-coenzyme A (CoA) transferase, which are present in 
bacteria of the Clostridium cluster XIVa, Roseburia-Eubacterium rectale cluster and Faecalibacterium 
prausnitzii, all known as important butyrate producers [26]. Furthermore, the pectin diet resulted in a 
decrease of Bacteroides spp. and a higher level of butyrate [26]. Although pectin is an important 
contributor to gut health, exploring the combined effects of apple polyphenols and fiber seems prudent. 
Moreover, dietary fiber can form a complex with polyphenols referred as “antioxidant dietary  
fiber” [114] protecting antioxidants which can reach the colon and have local effects in the gut [19]. 
Apple pomace, a by-product of juice production, and a high source of fiber and polyphenols, has been 
shown to have beneficial effects by decreasing caecal pH and increasing SCFA in rats compared with a 
control diet [114]. Similarly, apple pomace extraction juice colloids (5%) increased Bacteroidaceae, 
caecal content weight and SCFA concentration, mainly acetate and propionate, indicating microbial 
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fermentation of pectin [24]. An alcohol apple pomace extract rich in insoluble fiber further increased 
butyrate concentration and Eubacterium rectale cluster compared to the juice colloids and the  
control [24]. In addition, the same group reported an increase in Lactobacillus and Bifidobacterium 
counts after the administration of juice extracted from apple pomace [25]. Moreover, the observed 
elevated acetate was associated with pectin fermentation whereas the higher total SCFA were linked to 
polyphenols, including quercetin-3-glucoside [25]. A synergistic interaction of apple pectin and 
polyphenols have been reported on large intestinal fermentation and lipid metabolism [115], and rat 
cecum fermentation [116]. In contrast, although an intake of 5% unprocessed apple pomace, 
containing 61% of fiber and 0.23% of polyphenols increased caecal SCFA compared to a control diet, 
reducing or removing the polyphenol fraction caused further beneficial effects by increasing the 
glycolytic activity of caecal microbiota, beneficially modifying the ratio of caecal SCFA and 
branched-chain fatty acids (BCFA), and decreasing caecal ammonia and colonic pH [117]. Finally, in a 
recent ex vivo study the microbiota balance after in vitro fermentation of faeces from diet induced 
obese mice with nondigestible apple compounds including dietary fiber, extractable and  
non-extractable phenolics, resembled that in lean controls [118]. Nevertheless, it should be noted that 
animals metabolize apple components differently from humans [26]. Moreover, the main site of 
fermentation in rats is the cecum, whereas in humans this occurs in the colon. Thus, human studies are 
necessary to explore these effects. A summary of the in vivo studies is presented in Table 2. 
3.1.3. Human Studies 
To our knowledge, only two human studies have explored the effects of apples on gut microbiota 
(Table 2). In a small scale intervention study (n = 8), 2 apples per day for 2 weeks significantly 
increased fecal bifidobacteria, while reducing Enterobacteriaceae and lecithinace-positive clostridia, 
including C. perfringens [27]. A trend for increased levels of Lactobacillus, Streptococcus and 
Enterococcus was also reported [27]. However, this study did not use culture independent 
microbiology techniques and a control treatment, limiting the ability to accurately assess apple induced 
changes. In a recent 4 week-study of 23 healthy subjects whole apple and pomace consumption 
lowered fecal pH and resulted in differences in denaturing gradient gel electrophoresis (DGGE) 
profile. However, a potential modulation of the gut microbiota population was not confirmed by 
quantitative PCR [15]. There is a need to further explore the impact of apple consumption on both the 
composition and metabolic output of the gut microbiota in suitable designed, well powered, controlled, 
dietary intervention studies using the most up to date culture independent microbiological techniques. 
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Table 2. Effects of apples and apple components on gut microbiota composition and activity. 
Type of Study Duration-Diets-Daily Dose Techniques Used Results Author 
Animal 
(Wistar rats) 
6 weeks, 10 rats for each group: 
Control diet or 
5% apple pomace (AP) 1B-juice colloids extract 
(54.3% soluble and 2.6% insoluble fiber) or 
5% AP 4B-juice colloids extract, rich in soluble fiber 
(78.3% soluble and 1.8% insoluble) or 
5% alcohol AP extract, rich in insoluble fiber (22.9% 
soluble and 73.3% insoluble) 
FISH (caecal) 
Plate count (feaces) 
B-juice AP extracts:  
Total SCFA, acetate and propionate: ↑, pH: ↓  
Bacteroidaceae: ↑ (faeces) 
Alcohol AP extract:  
Total SCFA and butyrate: ↑, pH: ↓  
Bacteroidaceae: ↑ (faeces)  
Eubacterium rectale: ↑ (caecal) 
Sembries et al.  
(2003) [24] 
Animal 
(Wistar rats) 
4 weeks, 12 rats for each group: 
Control diet or 
Extraction juice from apple pomace  
Plate count Total SCFA and acetate: ↑, pH: ↓ 
Lactobacillus: ↑, Bifidobacterium: ↑ 
Primary bile acids and neutral sterols: ↑ 
Secondary bile acids: ↓ 
Sembries et al.,  
2006 [25] 
Animal 
(Fischer rats) 
4 weeks, 8 rats for each group: 
Control diet or 
10 g apple or 
7% apple pectin 
qPCR Apple:  
Butyrate:↑,  pH: ↓, Bacteroides spp: ↓ 
Apple pectin:  
Butyrate:↑,  pH: ↓, Bacteroides spp: ↓, Clostridium coccoides: ↑ 
Licht et al.,  
2010 [26] 
Animal ex vivo 
(mice) 
Granny Smith apple fermented in vitro from faeces 
from diet induced lean (control) and obese mice. 
qPCR Firmicutes, Bacteroidetes, Enterococcus, Enterobacteriaceae, 
Escherichia coli and Bifidobacterium abundances from obese mice 
tended to be similar to lean mice after apple fermentation.  
Condezo-Hoyos et al., 
2014 [118] 
 
Human  2 weeks, 8 subjects: 
2 apples  
Plate count Bifidobacteria: ↑ 
Clostridia: ↓, Enterobacteriaceae: ↓ 
Shinohara et al.,  
2010 [27] 
Human  
 
Randomized, 
single blinded, 
controlled, 
crossover 
4 weeks, 23 subjects: 
Control: period of restricted diet or 
550 g whole apples or 
22 g apple pomace or 
500 ml clear apple juice or 
500 ml cloudy apple juice  
qPCR No changes in bacteria composition. 
pH: ↓ 
Ravn-Haren et al., 2012 
[15] 
↑: significant increase; ↓: significant decrease; SCFA: short chain fatty acids; FISH: fluorescence in situ hybridization; qPCR: quantitative polymerase chain reaction.
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3.2. Impact of the Gut Microbiota on Apple Components—Focus on Polyphenols 
3.2.1. In vitro 
A study by Deprez et al. (2000) was one of the first to show that PA polymers can be degraded by 
the human colonic microbiota into low molecular weight aromatic acids with different hydroxylation 
profile and aliphatic side chain length [119]. From the initial 14C labelled PAs, 9%–22% found in the 
metabolite pool and the major microbial metabolites included 3-hydroxyphenylpropionic acid,  
3-phenylpropionic acid, 4-hydroxyphenylpropionic acid and 4-hydroxyphenylacetic acid [119]. The 
ability of the human gut microbiota to ferment apple PAs with different chain length was explored for 
pure apple, enzymatically digested apple, isolated cell walls, isolated PAs, cell walls-PAs or ciders 
from Marie Menard and Avrolles apple varieties [107]. The main microbial metabolites included  
3-(3,4-dihydroxyphenyl)propionic acid, 3-(3-hydroxyphenyl)propionic acid, 3-phenylpropionic acid 
and benzoic acid derived from apple flavanols and 2-(3,4-dihydroxyphenyl)acetic acid and  
2-(3-hydroxyphenyl)acetic acid from flavonols [107]. The DP of PAs can affect microbial conversions. 
Increasing the DP might suppress the extension of microbial metabolism and formation of phenolic 
acids. Moreover, the isolated long chain PAs inhibited the formation of SCFA from cell walls and 
carbohydrates naturally present in the fecal inoculum which was not noticeable when the PAs were 
combined with the apple cell walls [107]. Differences in the extent of microbial degradation between 
monomeric and oligomeric flavanols have been shown in other in vitro studies [120,121]. Recently,  
Ou et al. (2014) explored the human microbial metabolism of (−)-epicatechin, (+)-catechin, PC B2 and 
partially purified apple PCs (Granny Smith variety) [122]. The major microbial metabolites of  
(−)-epicatechin, (+)-catechin and PC B2 were benzoic acid, 2-phenylacetic acid, 3-phenylpropionic 
acid, 5-(3′-hydroxyphenyl)-γ-valerolactone and 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone and 
accounted for over 70% of the total metabolites [122]. Fermentation of all the substrates including 
apple PCs further produced 2-(3-hydroxyphenyl)acetic acid, 2-(4-hydroxyphenyl)acetic acid,  
2-(3,4-dihydroxyphenyl)acetic acid, 3-(3-hydroxyphenyl)propionic acid and hydroxyphenylvaleric 
acid. Apple PCs produced the lowest amount of metabolites but demonstrated the highest quantity of 
3-(3-hydroxyphenyl)propionic acid. Moreover, 2-(3,4-dihydroxyphenyl)acetic acid  was only 
detectable from PC B2 and apple PCs. The lowest recovery of metabolites after 24 h fermentation were 
observed for the purified apple PCs compared to the other substrates supporting the theory that PCs 
might slow down the microbiota metabolism [122].  
Hydroxycinnamic acids that reach the colon may undergo intensive microbial metabolism. 
Chlorogenic acid has been shown to be converted to 3-(3-hydroxyphenyl)propionic acid and  
benzoic acid [123] whereas Rechner et al. (2004), observed conversion to caffeic acid,  
3-(3,4-dihydroxyphenyl)propionic acid, followed by the formation of 3-(3-hydroxyphenyl)propionic 
acid and finally 3-phenylpropionic acid [124]. Colonic absorption of the last two metabolites can lead 
to the production of 3-hydroxyhippuric acid and hippuric acid in the liver [124]. 
Quercetin glycosides may also reach the colon and could serve as a substrate for human gut 
bacteria. It has been shown that once the quercetin molecule is released by the action of microbial 
enzymes it can be degraded to 3,4-dihydroxyphenylacetic acid [125]. Phloroglucinol appears as a 
transient intermediate which might be further degraded to acetate and butyrate [126]. Eubacterium 
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ramulus and Flavonifractor plautii, among other bacteria are capable of metabolizing  
quercetin [125,127]. Finally, it is worth mentioning that different fecal donors possess a different 
intestinal microbiota composition causing a high individual variation and thus, caution is necessary 
when comparing these in vitro results [107]. 
3.2.2. In Vivo—Animal and Human Studies 
The urinary metabolome of rats was investigated using an untargeted mass spectrometry based 
approach after the consumption of 7% apple pectin or 10 g of raw apple compared to a standard  
diet [128]. The metabolites and potential markers of apple intake that appear in urine included quinic 
acid, m-coumaric, hippuric acid and 3-hydroxy hippuric acid, all related to gut microbial metabolism 
predominantly of chlorogenic acid. Dihydroxyphenyl-γ-valerolactone an important microbial 
metabolite of (−)-epicatechin was also identified [128]. The metabolites related to pectin consumption 
were pyrrole-2-carboxylic acid, 2-furoylglycine and 2-piperidinone. Gut microbial metabolism was 
also suggested after alterations in plasma metabolite levels in rats fed with fresh apples [129].  
Animal studies result in different bioconversions compared to humans. For example, although 
human gut microbiota can metabolize PAs into low molecular weight phenolic acids, these may be 
poorly metabolized in rats [130,131]. To our knowledge no human study has explored the formation of 
polyphenol gut microbiota metabolites after apple consumption. However, in a recent study, changes 
in the blood metabolome after different apple product consumption suggested altered gut  
microbial metabolism [132]. Studies on cocoa derived products, which are a rich source of oligomeric  
and polymeric PCs, with similar chemical structures to apples, identified in humans  
colonic microbial-derived phenolic catabolites, mainly 3-hydroxyphenylpropionic acid,  
3,4-dihydroxyphenylacetic acid, 3-hydroxyphenylacetic acid and 3-hydroxybenzoic acid [133].  
4. Cardiovascular Disease Risk 
Cardiovascular disease risk factors including, dyslipidemia, endothelial dysfunction and 
inflammation are some of the biggest health challenges today. Epidemiological evidence suggests that 
flavonoid consumption may reduce cardiovascular disease risk and apples, as a rich source, may be a 
major contributor [7,9]. In a Finnish study of 10,054 men and women the link between flavonoid 
intake and several chronic diseases was explored. Apple intake was strongly inversely correlated with 
ischemic heart disease mortality, thrombotic stroke and total mortality [7]. Apples were also associated 
with a reduced risk of coronary heart disease and total cardiovascular disease mortality, as shown in 
the Iowa Women’s Health Study, where 34,489 subjects free of CVD were followed up for 16 years [9]. 
In contrast, a prospective study of 38,445 women [134] and a 5 year follow up of 805 elderly  
men [135] found only non-significant inverse associations between CVD risk and apple consumption. 
4.1. Lipid Metabolism 
4.1.1. Animal Studies 
The effects of whole apples or specific apple constituents on lipid metabolism have been 
investigated in a number of animal studies (Table 3). Fiber, mainly pectin, was considered initially as 
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the main apple component responsible for the cholesterol lowering properties [136–138] and as shown 
by Sanchez et al. (2008) to a similar extent as oat β-glucan which is known for its hypocholesterolemic 
effects [35]. Apple polyphenols can also play an important role. Unripe apples, rich in PCs, 
significantly decreased serum and liver cholesterol, as well as atherogenic indices, after a 
hypercholesterolemic diet [139]. Polyphenols and in particular catechin, epicatechin and PC B1 were 
considered responsible for the lipid lowering effects of a portuguese apple variety (Bravo de Esmolfe) 
in hypercholesterolemic rats [140]. Other studies indicated that apple polyphenols could compensate 
the dyslipidemic effects of a high cholesterol diet [20,140–143]. However, the combined effect of 
apple fiber and polyphenol proved more efficient in reducing plasma cholesterol levels [115], and 
hepatic cholesterol [144] than the individual components. An apple diet consisting of 10% or 15% 
lyophilized apple improved lipid metabolism and significantly decreased TC respectively [145,146]. 
Increasing the amount of lyophilized apple to 20%, lowered plasma cholesterol, low density 
lipoprotein-cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and triacylglycerol 
(TAG) concentrations in liver and heart in hypercholesterolemic genetically obese Zucker rats 
compared to a control diet [147]. Apple pomace, reduced TC, TAG and serum atherogenic  
index [117]. The importance of apple pomace on lipid metabolism was also demonstrated in a more 
recent study [148] whereas Sembries et al., (2004) did not find effects on serum lipid levels [149]. 
Finally, apple peel had a higher positive effect on plasma lipids compared to the pulp which was 
attributed to the higher content of bioactive components in the peel [150]. 
4.1.2. Human Studies 
Apple pectin has been shown to decrease plasma TC in humans [151]. A meta-analysis concluded 
that 1 g of pectin could decrease TC and LDL-C by 0.070 and 0.055 mmol/L respectively [37]. The 
combined effect of apple fiber and gum arabic supplemented in an apple juice decreased TC (8%) and 
LDL-C (14%) in mildly hypercholesterolemic men compared to the unsupplemented apple juice [152]. 
Pure apple polyphenols can also decrease TC and LDL-C in a dose-depended manner as was shown in 
mild hypercholesterolemic subjects [11]. Although the main effects were observed after the highest 
concentration (1500 mg), which is considerably higher with the amount found in an apple, a later study 
by the same group found similar effects with 600 mg, together with a decrease in visceral fat [12]. In 
contrast, a cloudy apple juice containing 800 mg of polyphenols had no effects on blood lipids but a 
significant interaction between IL-6-174 G/C polymorphism and body fat reduction [13]. It was 
identified in an early study that the consumption of 3 apples per day for 4 months significantly reduced 
TC and increased HDL-C in 76 mildly hypercholesterolemic subjects compared to a control group 
(less than 3 apples per week) [153]. The effects of dried apples were explored in a long intervention 
parallel study (12 months) of 160 postmenopausal women compared to dried plum (comparative 
control) [14]. TC concentration was significantly decreased at 6 months compared to the control, and 
at 3 months within the intervention group. More recently, 23 healthy subjects consumed whole apples 
(550 g), apple pomace (22 g), clear and cloudy apple juices (500 ml) daily, each for 4 weeks including 
a control period [15]. Compared to the control period only, trends were observed for a reduction in 
LDL-C after whole apple (6.7%), pomace (7.9%) and cloudy apple juice (2.2%) intake [15].  
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Table 3. Effects of apples and apple components on lipid metabolism in animals. 
Animal Type- 
Number (n)- 
Study Duration-Design 
Diets-Daily Dose Results Author 
Wistar rats 
 
n = 12 each group 
 
3 weeks/parallel 
Control diet  
or 
15% lyophilized apple 
TC: ↓ 9.3%  
Faecal TS excretion: ↑ 
Faecal TC excretion: ↑ 
Aprikian et al., 2001 [145] 
 
Wistar rats 
 
n = 10 each group 
 
40 days/parallel 
Control cholesterol (3g/kg) diet  
or 
10% apple pomace fiber  
TC: ↓ 18.4%  
LDL-C: ↓ 31.2%  
HDL phospholipids: ↑ 19%  
TAG: ↓ 14.8%  
Liver TC: ↓ 26.3%  
Leontowicz et al., 2001[138] 
Lean (Fa/-) and obese (fa/fa) 
Zucker rats 
 
n = 8 each group 
 
3 weeks/parallel 
Control diet   
or 
20% lyophilized apple 
 
 
TC: ↓ 22% (Obese group) 
LDL-C: ↓ 70% (Obese group) 
HDL-C: ↓ 26% (Obese group) 
Liver and heart TAG: ↓ (Obese group) 
Faecal BA excretion: ↑ (Lean group) 
Aprikian et al., 2002 [147] 
Wistar rats 
 
n = 8 each group 
 
4 weeks/parallel 
Control cholesterol (1%) diet  
or 
10% whole dry apples  
 
TC: ↓ 20%  
LDL-C: ↓ 32.6%  
TAG: ↓ 17%  
Liver TC: ↓ 29.6%  
Leontowicz et al., 2002[146] 
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Table 3. Cont. 
Wistar mild 
hypercholesteolemic rats 
 
n = 10 each group 
 
3 weeks/parallel 
Control diet  
or 
Freeze dried pectin, 5% (PEC)  
or 
High polyphenol cider apple extract, 10% 
(PL)  
or 
Mixed diet: PEC + PL  
TC: ↓ 24% (PEC + PL)  
TAG: ↓ 29% (PL) 
          ↓ 35% (PEC + PL) 
Liver TC and TAG: ↓ (PEC and PEC + PL) 
Faecal BA excretion: ↓ (PEC and PEC + PL) 
Faecal NS excretion: ↑ (PEC and PEC + PL)   
Aprikian et al., 2003 [115] 
Wistar rats 
 
n = 8 each group 
 
4 weeks/parallel 
Control cholesterol (1%) diet  
or 
apple peel, 10% (Apeel)  
or 
apple pulp, 10% (Apulp) 
TC: ↓ 21.6% (Apeel), ↓ 19.4% (Apulp) 
LDL-C: ↓ 35.3% (Apeel), ↓ 33.3% (Apulp) 
TAG: ↓ 18% (Apeel), ↓ 14.6% (Apulp) 
Liver TC: ↓ 31.6% (Apeel), ↓ 27% (Apulp) 
Leontowicz et al., 2003[150] 
Sprague-Dawley rats 
 
n = 8 or 9 each group 
 
30 days/parallel 
Control cholesterol (0.5%) diet  
or 
0.2% apple polyphenols rich in oligomeric 
procyanidins (AP)  
or 
0.5% AP  
or 
1% AP  
TC: ↓ (all treatments) 
HDL-C: ↑ (1% AP), ↓ (0.2% AP) 
HDL-C/TC: ↑ (0.5% and 1% AP) 
Liver TC: ↓ (0.5% and 1% AP) 
Atherogenic indices: ↓ (0.5% and 1% AP) 
Faecal acidic and neutral steroid excretion: ↑ (0.5% and 1% AP)  
Osada et al., 2006 [139] 
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Table 3. Cont. 
ApoE deficient mice (apoE-
KO) 
 
n = 16 each group 
 
4 months/parallel 
Control diet  
or 
apple polyphenols (AP), equivalent to  
1.6 g/day for humans  
or 
apple fiber (AF), equivalent to 50 g/day for 
humans  
or 
Mixed diet: AP + AF 
Liver TC: ↓ 22% (AP + AF) 
Atherosclerotic lesions: ↓ (all treatments) 
 
Auclair et al., 2008 [144] 
 
Hypercholesterolemic 
hamsters 
 
n = 8 each group 
 
12 weeks/parallel 
Control atherogenic diet  
or 
apple (A)  
or 
apple juice (AJ) 
Equivalent to daily consumption of 600 g 
apples or 500 ml of juice for humans 
 
TC: ↓ 11% (A)  
       ↓ 24% (AJ) 
Non HDL-C: ↓ 30% (A) 
                      ↓ 55% (AJ) 
TC/HDL-C: ↓ 25% (A) 
                     ↓ 38% (AJ) 
Aortic fatty streak area: ↓ 48% (A) and 60% (AJ)  
Decorde et al., 2008 [142] 
 
Golden Syrian hamsters 
 
n = 13 each group 
 
6 weeks/parallel 
Control atherogenic diet, 0.1% cholesterol 
or 
0.3% apple polyphenols (AP)  
or 
0.6% AP  
 
HDL-C: ↑14.7% (0.3% AP) 
              ↑16.5%  (0.6% AP) 
Non HDL-C: ↓ 20% (0.3% AP) 
                      ↓ 36.7% (0.6% AP) 
TAG: ↓ 31.9% (0.6% AP) 
Faecal BA excretion: ↑ (0.3% and 0.6% AP) 
Faecal NS excretion: ↓ (0.3% and 0.6% AP) 
Lam et al., 2008 [143] 
 
Zucker fatty rats 
 
n = 10 each group 
 
15 weeks/parallel 
Control diet  
or 
High methoxylated apple pectin, 10% 
(HMAP)  
or β-glucan, 10% 
TC: ↓ (HMAP and β-glucan) 
HDL-C: ↑ (HMAP) 
Non HDL-C: ↓ (HMAP and β-glucan) 
TAG: ↓ (HMAP and β-glucan, higher effect for HMAP) 
Sanchez et al., 2008 [35] 
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Table 3. Cont. 
Rabbits 
 
n = 8 each group 
 
2 months/parallel 
Control cholesterol (1%) diet  
or 
5 ml apple juice (low dose, LD) 
or  
10 ml apple juice (high dose, HD) 
TC: ↓ 75% (LD), ↓ 77% (HD) 
LDL-C: ↓ 70% (HD) 
HDL-C: ↑ 86%  (HD) 
TAG: ↓ 61% (LD), ↓ 59% (HD) 
Atherosclerotic lesions: ↓ (LD and HD) 
Setorki et al., 2009 [20] 
 
 
 
 
Wistar rats 
 
n = 8 each group 
 
4 weeks/parallel 
Control diet  
or 
5% AP: apple pomace (61% dietary fiber 
(DF), 0.23% polyphenols (PP))  
or 
5% APE: ethanol extracted apple pomace 
(66% DF, 0.1% PP)  
or 
5% APA: ethanol/acetone extracted apple 
pomace (67% DF, 0.01% PP) 
TC: ↓ 19% (AP and APA) 
TAG: ↓ 26% (APA)  
          ↓ 38% (AP) 
Atherogenic index, log TAG/HDL-C: ↓ (AP) 
 
 
Kosmala et al., 2011 [117] 
 
 
Wistar hypercholesterolemic 
rats 
 
n = 8 each group 
 
30 days/parallel 
 
Control cholesterol (2%) diet  
 
20% apples from 3 different varieties: 
- Golden (G) 
- Malapio da serra (MS) 
- Bravo de esmolfe (BE) (highest 
polyphenol and antioxidant 
capacity) 
TC: ↓ 21%  (BE) 
LDL-C: ↓ 20.4% (BE) 
TAG: ↓ 27.2% (BE) 
 
Serra et al., 2012 [140] 
 
 
Sprague–Dawley rats 
 
n = 8 each group 
 
5 weeks/parallel 
Control high fat diet  
or 
10% apple pomace (AP) 
or 
10% apple juice concentrate (AC) 
 
 
 
TC: ↓ 23% (AP), ↓ 22% (AC) 
LDL-C: ↓ 34% (AP), ↓ 32% (AC) 
HDL-C: ↑ 12%  (AP)  
HDL-C/TC: ↑ (AP and AC) 
TAG: ↓ 30% (AP), ↓ 27% (AC) 
Liver TC: ↓19% (AP)  
Liver TAG: ↓ 21% (AP), ↓ 10% (AC)  
Atherogenic index: ↓ (AP and AC) 
Cho et al., 2013 [148] 
 
↑: significant increase compared to the control diet; ↓: significant decrease compared to the control diet; TC: total cholesterol; LDL-C: low density lipoprotein-cholesterol; HDL: high density 
lipoprotein; TAG: triacylglycerols; TS: total steroids; NS: neutral sterols; BA: bile acids. 
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In contrast, some studies concluded that apples or apple components did not show any significant 
beneficial effects with a limited number suggesting some adverse effects. The lipid lowering properties 
of gum arabic-pectin supplementation was not observed in a study of 85 hypercholesterolemic  
subjects [154]. Consumption of clear apple juice resulted in a significantly higher level of TC and  
LDL-C compared to whole apple or apple pomace [15]. Blood lipid levels did not change after the 
consumption of fresh whole apples [155,156] or apple juice [155]. Apple consumption increased TAG 
levels in hypercholesterolemic overweight women in Brazil after a period of 12 weeks [16]. However, 
a small but significant weight loss of 1.22 kg, was also reported after the fruit consumption, suggesting 
beneficial modification of the energy intake and satiety [16]. Similarly, a control group (no apple 
intake) of overweight men decreased serum TAG and very low density lipoprotein compared to the 
intervention apple group [157]. The most recent human intervention studies are presented in Table 4.  
In general, the majority of these human studies provide some evidence to support beneficial effects 
on lipid metabolism, mainly TC reduction. In a mini-review it was reported that 3 apples per day could 
reduce cholesterol by 5%–8% (approximately 0.5 mmol/L) [158]. The specific amount and type of 
polyphenols and fiber that are responsible for these effects requires exploration. The delivery matrix of 
these bioactive components is also crucial. Beneficial effects are shown with fresh or dry apples and 
cloudy apple juice, however clear apple juice has been associated with adverse effects. Apple pomace 
is also a valuable material since it contains an important fraction of the polyphenols and fiber of the 
whole apple. More large scale randomized and well controlled human intervention studies are required 
to confirm these effects and to explore the potential mechanisms using realistic doses that can be 
successfully incorporated to a habitual human diet. 
4.1.3. Potential Lipid-Lowering Mechanisms 
Modulation of Bile Acid Enterohepatic Circulation  
Bile acids (BAs) are known to play an important role in lipid metabolism. BA synthesis is 
performed in the liver and regulated mainly by cholesterol 7α-hydroxylase (CYP7A1), an enzyme that 
converts cholesterol to cholic acid (CA) and chenodeoxycholic acid (CDCA) as the primary  
forms [159]. Prior to their secretion via the gall bladder, BAs are conjugated with the amino acids 
taurine or glycine to form bile salts. After a meal bile salts enter the duodenum, facilitating the 
metabolism and the absorption of dietary lipids. Most bile salts are then reabsorbed in the distal ileum. 
However, a small percentage escape reabsorption and are deconjugated by gut bacteria. These are then 
converted into secondary bile acids, which are either excreted in the faeces or absorbed and return back 
to the liver where together with the absorbed primary bile acids and salts are reconjugated and 
resecreted completing one cycle of the enterohepatic circulation [159]. The enzyme responsible for the 
deconjugation of bile salts is bile salt hydrolase (BSH), which has been isolated from several gut 
bacteria including species of bifidobacteria and lactobacilli [160]. Once deconjugated, bile acids are 
less soluble leading to reduced reabsorption and increased faeces excretion [161]. Consequently more 
cholesterol is removed from the circulation for de novo synthesis [161].  
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Table 4. Effects of apples and apple components on blood lipid levels in humans. 
Subjects-Study Duration-Design Diets-Daily Dose Results Author 
25 healthy men/women 
 
6 weeks 
 
Randomized, crossover 
340 g apple  
or 
375 ml apple juice 
No changes: TC, LDL-C, HDL-C and TAG Hyson et al., 2000 [155] 
 
49 hypercholesterolemic, 
overweight women 
 
12 weeks (35 women) 
 
Randomized, parallel 
300 g apple  
or 
300 g pear  
or 
60 g oat cookies 
TC: ↓ (oat group) 
TAG: ↑ (fruit group) 
de Oliveira et al., 2003[16] 
 
 
48 hypercholesterolemic 
men/women 
 
4 weeks 
 
Randomized, double-blinded, 
placebo-controlled, parallel 
Control: supplement without polyphenols 
or 
Low dose: 300 mg apple polyphenols (AP)  
or 
Medium dose: 600 mg AP  
or 
High dose: 1500 mg AP 
TC: ↓ 4.5% (from baseline for High dose)  
LDL-C: ↓ 7.8% (from baseline for High dose)  
No changes: HDL-C and TAG 
 
Nagasako-Akazome et al., 
2005 [11] 
 
15 elderly  
4 weeks 
Fresh apples  (2 g/kg body weight, 
approximately 1 apple) 
No changes: TC, LDL-C, HDL-C and TAG Avci et al., 2007 [156] 
48 moderately obese men/women 
 
12 weeks 
 
Randomized, double-blinded, 
placebo-controlled, parallel 
Control: capsules without polyphenols 
or 
600 mg apple polyphenols capsules 
 
 
TC: ↓ (from baseline and control group) 
LDL-C: ↓ (from baseline) 
No changes: HDL-C and TAG 
VFA: ↓ (from control group) 
Adiponectin: ↑ (from control group) 
Nagasako-Akazome et al., 
2007 [12] 
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Table 4. Cont. 
46 overweight, hyperlipidemic men 
 
8 weeks 
 
Randomized, controlled, parallel 
Control: no apple intake 
or 
300 g apple 
No changes: TC, LDL-C and HDL-C 
TAG: ↓ (in control group compared with the apple group) 
VLDL-C: ↓ (in control group compared with the apple group) 
Vafa et al., 2011 [157] 
 
68 overweight men  
 
4 weeks 
 
Randomized, blinded, placebo-
controlled, parallel 
Control: beverage without polyphenols 
or 
750 ml cloudy apple juice 
No changes: TC, LDL-C, HDL-C and TAG 
% total body fat: ↓ (from control group) 
Body fat mass: ↓ (only in IL-6-174 C/C variant compared with 
G-allele carriers). 
Barth et al., 2012 [13] 
 
160 postmenopausal women 
 
1 year 
 
Randomized, single blinded, 
controlled, parallel 
Dried plum (comparative control) 
or 
75 g dried apples 
TC: ↓ (from control group) 
TC: ↓ 13% (from baseline) 
LDL-C: ↓ 24% (from baseline) 
TC:HDL-C: ↓ (from baseline) 
LDL:HDL-C: ↓ (from baseline) 
No changes: HDL-C and TAG 
Chai et al., 2012 [14] 
23 healthy men/women 
 
4 weeks 
 
Randomised, single blinded, 
controlled, crossover 
Control: period of restricted diet 
or 
550 g whole apples (WA) 
or 
22 g apple pomace (AP) 
or 
500 ml clear apple juice (AJ) 
or 
500 ml cloudy AJ 
Treatment resulted in significant effects in TC and LDL-C. 
Clear AJ: ↑ 5% TC, ↑ 6.9% LDL-C (compared with WA and 
AP) 
No changes: HDL-C and TAG 
Ravn-Haren et al, 2012 
[15] 
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Table 4. Cont. 
20 healthy young men/women 
 
4 weeks 
 
Randomized, crossover 
500 ml of two cloudy apple juices: 
 
510 mg/L catechin equivalent and 60 mg/L 
vitamin C (VCR) 
or 
993 mg/L catechin equivalent and 22 mg/L 
vitamin C (PR) 
TC: ↓ 4% (VCR) 
No changes: LDL-C, HDL-C and TAG 
Soriano-Maldonado et al., 
2014 [162] 
↑: significant increase; ↓: significant decrease; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; VLDL-C: very low density lipoprotein cholesterol; HDL-C: high density 
lipoprotein cholesterol; TAG: triacylglycerols; VFA: viscelar fat area. 
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Animal studies showed that apple polyphenol supplementation increased the excretion of bile acids 
in faeces [139,143]. This may be related to binding of polyphenols with bile acids enhancing their 
excretion in the faeces (Table 2). Apple polyphenols and mainly PCs may directly enhance the activity 
of CYP7A1, the first and rate-limiting enzyme in bile acid synthesis [139]. Moreover, it has been 
suggested that catechins and PCs could inhibit intestinal cholesterol absorption by affecting micellar 
solubility and may also increase direct excretion of cholesterol and lipids in faeces [163,164].  
Apple pectin as a soluble, nondigestible and viscous fiber has the ability to increase bile acids 
and/or cholesterol passage to the colon and faeces through formation of complexes and may also 
interrupt the enterohepatic circulation and reduce plasma cholesterol levels [136,137,147,149]. In 
contrast a decreased faecal BA and increased neutral sterol excretion after intake of apple pectin (alone 
or combined with apple polyphenols) suggests cholesterol lowering properties in parallel with a high 
rate of bile acid reabsorption [115]. Further studies are necessary to explore this discrepancy and 
further assess the complete bile acid pool in circulation.  
Additionally, intestinal microbiota may play a role in conversion of cholesterol to coprostanol 
which is subsequently excreted in faeces [165]. Deconjugated BAs can also act as signalling molecules 
affecting activation of the farnesoid X receptor (FXR), a nuclear receptor that inhibits hepatic de novo 
lipogenesis and is responsible for other physiological processes which can impact on cholesterol 
catabolism and lipid absorption from the intestine [166–169].  
Modification of Lipid Metabolism  
Apple polyphenols may affect lipid metabolism through several other mechanisms including, 
activation of fatty acid β-oxidation and cholesterol catabolism in the liver [139,164,170], inhibition of 
hepatic fatty acid synthesis [141,164], decreasing cholesterol esterification and secretion of  
apoB-containing lipoproteins [171] and suppression of cholesteryl ester transport protein (CETP) 
activity improving the distribution of cholesterol in lipoproteins [143]. Moreover, apple polyphenols 
have been associated with a reduction in total body weight gain [24], adipose tissue  
weight [141,148,172], visceral fat [12,164] and leptin levels [164]. PAs can inhibit the action of 
digestive enzymes such as lipase and amylase with beneficial effects on lipid and glucose metabolism. 
Oligomeric apple PCs have been shown to inhibit pancreatic lipase activity, with increased inhibition 
associated with a high degree of polymerization, affecting postprandial TAG absorption [173]. 
Upregulation of lipoprotein lipase (LPL) activity has been suggested as an alternative mechanism of 
TAG lowering [174]. PAs may also regulate lipid metabolism by activating FXR and by modulating 
other nuclear receptors such as small heterodimer partner (SHP) and peroxisome proliferator-activated 
receptors (PPARs) as well as transcription factors like steroid response element binding protein 1 
(SREBP1) [175–177]. In addition, apple phenolic compounds have been associated with a reduction in 
LDL oxidation, an important contributor to atherosclerosis, as has been shown in in vitro [178–180]  
or in animal models [140,147,181]. 
Pectin has a major role in cholesterol lowering by inhibiting cholesterol absorption and uptake, 
influencing micelle formation and affecting transit time [35,145]. The origin and physicochemical 
properties of pectin, including molecular weight, DM and viscosity affect the efficacy of the  
mechanisms [34,35,37,136,137,182]. For example, by increasing the DM a greater proportion of bile 
acids are transported to the distal colon [183] increasing faecal excretion [149,183]. Production of 
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SCFA can independently affect these activities. Butyrate plays a major role in colonic function, in 
addition it has been shown to inhibit liver cholesterol synthesis, whereas acetate and propionate have 
an impact on metabolic processes at a systemic level, and may possess opposing effects on lipid 
metabolism [78]. While propionate may inhibit cholesterol synthesis, acetate could increase hepatic 
lipogenesis, however, the results are inconsistent [78]. Finally, the potential lipid lowering effects of 
apples are probably due to the combined/synergistic effects of polyphenols and fiber rather than the 
individual components. Human intervention studies are necessary to support these mechanisms. 
4.2. Vascular Function and Blood Pressure 
Endothelial dysfunction is considered as an early marker in the pathogenesis of atherosclerosis and 
its complications [184]. Thus, endothelial function can serve as an indication for cardiovascular health. 
Nitric Oxide (NO) is an important endothelium-derived vasodilator produced from its precursor  
L-arginine via the enzymatic action of endothelial NO synthase (eNOS) [185]. A defect in the NO 
production is considered as the main mechanism of endothelial dysfunction and thus, impaired 
endothelium dependent vasodilation. Flavonoids have been shown to increase NO status, yet few 
human studies have explored the potential role of apple polyphenols on vascular function and blood 
pressure. Higher flow mediated dilation (FMD) of the brachial artery, increased NO status and lowered 
systolic blood pressure was observed in 30 healthy subjects after the acute intake of an apple blend 
providing 184 mg of quercetin and 180 mg of (−)-epicatechin [17]. Flavonoids can increase NO by 
stimulating eNOS activity, protect NO from free radicals and inhibit the synthesis of vasoconstrictor  
endothelin-1 [186,187]. Similarly, both a low and a high apple puree intake (230 g) containing 25 and 
100 mg of epicatechin, respectively, increased plasma NO metabolite levels (at 6 h) and attenuated 
platelet reactivity (at 2 and 6 h) acutely in a study of 25 healthy subjects, but showed no effects after 
the daily consumption for 2 weeks [18]. No effect was reported in vascular function (assessed by 
FMD) after a 4-week cross over intervention with 40 g of lyophilized polyphenol rich apples, in  
30 hypercholesterolemic subjects [188]. Differences in the study design, food matrix, and polyphenol 
composition may account for the different results. Thus, an improvement in vascular function with 
dietary flavonoids has been shown mainly in acute studies with flavanol monomers, mainly  
(−)-epicatechin, considered responsible for these effects [189]. In the chronic study these monomers 
were not present in blood after a 10-hour fast which could explain the lack of effects. Although PAs 
microbial metabolites were present in the blood these had no apparent effect. This has been supported 
by a study claiming that gut microbial metabolites from PCs may not be responsible for the vascular 
effects [190]. However, other chronic studies providing PC rich sources such as chocolate and tea have 
shown beneficial effects and increased FMD (Hooper et al., 2008). Moreover, it has been shown  
in vitro that oligomeric PCs from apples, cocoa, red wine and cranberries were responsible for the 
inhibition of endothelin-1 mainly between the tetramer to heptamer range whereas monomers lacked 
any activity [191,192]. Similarly, large oligomers from grape seed and cocoa were responsible for 
endothelium-dependent vasodilation effects [192–194]. In addition, microbial polyphenol metabolites, 
that also appear after apple intake, including benzoic acids, cinnamic acids, chlorogenic acid and  
3-(3,4-dihydroxyphenyl)propionic acid have been shown to inhibit platelet activation and  
aggregation [195–197], angiotensin converting enzyme (ACE) action [198] and increase eNOS 
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expression [199]. Other studies have mainly focused on quercetin, a flavonol widely found in apples, 
and the potential hypotensive effects, as reviewed by Larson et al. [200]. A daily administration of  
730 mg of quercetin significantly decreased blood pressure in hypertensive, but not in prehypertensive 
subjects after 28 days [201]. No change in blood pressure was reported with 1000 mg quercetin and 
200 mg quercetin rhamnoglucoside in 27 normotensive subjects [202]. In contrast, a lower quercetin 
dose (150 mg) reduced blood pressure in subjects homozygous for the apolipoprotein E3 genotype 
only [203]. Apple peel has been shown to inhibit ACE activity in vitro, with quercetin-3-O-glucoside 
and the metabolite quercetin-3-O-glucuronic acid the most effective, suggesting antihypertensive 
properties [204]. Apples contain approximately 5 mg of quercetin per 100 g and thus any potential 
hypotensive effect may be due to synergistic interaction of the other polyphenols. Further chronic 
human studies are necessary to assess the impact of apple product consumption on vascular function 
and blood pressure. 
4.3. Inflammation 
Inflammation plays a key role in the pathology of atherosclerosis and coronary heart disease. There 
is a strong evidence base that polyphenols can exert anti-inflammatory/immunomodulatory  
activities [205,206], however, few studies have focused on the effects of apple polyphenols. The 
potential anti-inflammatory effect of apple PCs from 109 different cultivars was tested using cell-based 
assays [207]. Cultivars with a high PC content were able to inhibit nuclear factor-kappa B (NF-κB), a 
transcription factor involved in the induction of pro-inflammatory enzymes including  
cyclooxygenase-2 (COX-2) and the inducible nitric oxide synthase (iNOS), as well as the expression 
of inflammation related-genes such as those for tumor necrosis factor-alpha (TNF-α), interleukin-1β 
(IL-1β), IL-6 and IL-8 [207]. Jung et al. (2009) reported that PC B1, PC B2 and phloretin from apple 
juice extracts were related to an anti-inflammatory activity in vitro [208]. In an aninal study a high 
cholesterol diet supplemented with apple juice significantly decreased CRP levels in rabbits [20]. The 
administration of 7.6% lyophilized apple, rich in polyphenols, in particular PAs and hydroxycinnamic 
acids (Marie Menard cider variety), for 3 months, reduced colonic inflammation compared to a low 
polyphenol intake (Golden Delicious) in HLA-B27 transgenic rats, which develop spontaneous 
intestinal inflammation [19]. Interestingly, the high polyphenol variety had a dramatic impact on 
Bacteroides fragilis, a group of bacteria thought to be involved in the etiology or maintenance of 
inflammatory bowel disease (IBD). Inhibition of the NF-kB transcription factor, suggested as a 
potential mechanism [19] [207] has also been reported in other human cell studies with apple  
extracts [209,210]. The beneficial effect of Marie Menard apples was further confirmed in rats 
showing decreased colonic and systemic inflammation [22]. Furthermore apple pectin has been 
associated with anti-inflammatory effects in animal studies by down regulating pro-inflammatory 
cytokine expression and immunoglobulin production in the colon [211] and systematically by reducing 
plasma TNF-α [21]. Citrus pectin has been reported to inhibit iNOS and COX-2 expressions in 
lipopolysaccharide (LPS)-activated macrophages, with greater inhibition from the pectin with the 
higher DM [212]. Studies in humans are scarce. In an epidemiological study of 8335 US subjects the 
intake of apples was inversely associated with serum CRP levels [10]. Whereas an intervention study 
of 77 subjects showed no association between apple consumption and anti-inflammatory activity [213].   
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Gut microbiota composition may also modulate systemic inflammation. LPS, a constituent of  
gram-negative bacteria triggers the secretion of pro-inflammatory molecules. Elevated levels of LPS in 
blood circulation, mainly after a high fat diet contribute to metabolic endotoxemia which plays  
a major role in the pathophysiology of the metabolic syndrome and the progression of  
atherosclerosis [214–216]. Prebiotic dietary fiber, pectin and apple polyphenols through the potential 
modification of the intestinal microbiota may reduce metabolic endotoxemia by improving gut barrier 
function and reducing intestinal permeability and uptake of LPS [214,217–219]. In high fat fed mice, 
prebiotic oligofructose reduced endotoxemia and inflammation by increasing bifidobacteria  
levels [214]. Microbiota-derived polyphenol metabolites may also be responsible for these  
anti-inflammatory effects. It has been reported that quercetin can exert anti-inflammatory effects in 
rats, only when it is released from its glycosylated forms (e.g., quercetin 3-rhamnoside) by the action 
of the intestinal microbiota. [220]. Other in vitro and in vivo experiments have indicated that 
polyphenols found in apples may reduce intestinal inflammation in humans after microbial degradation 
suggesting beneficial effects, locally, at the intestinal level. [221]. Finally systemic effects have been 
reported in humans. Dihydroxylated phenolic acids, derived from the microbial degradation of PAs, 
mainly 3,4-dihydroxyphenylpropionic acid and 3,4-dihydroxyphenylacetic acid, significantly inhibited 
the secretion of pro-inflammatory cytokines including, TNF-α, IL-1β, and IL-6 in LPS stimulated 
peripheral blood mononuclear cells from 6 healthy volunteers [222]. 
5. Conclusions 
There is some supporting evidence to suggest that apples and apple components may beneficially 
modulate CVD risk factors. The strongest effects are related to lipid metabolism where evidence shows 
frequent apple consumption can reduce TC. Few studies have focused on vascular function and 
evidence for an anti-inflammatory activity is also limited and derived mainly from in vitro and animal 
studies. Microbiota-derived metabolites exert various biological activities and could contribute to the 
beneficial effects observed. A potential prebiotic impact of apple ingestion may be an important 
mechanism of CVD risk marker reduction. An increasing body of evidence highlights the important 
regulatory role mediated by microbe:host co-metabolic processes, especially bile acid metabolism. 
Both polyphenols, especially complex polyphenols such as PAs and dietary fiber, can influence the 
enterohepatic circulation by binding bile acids in the intestine, in a manner similar to pharmaceutical 
bile acid chelating agents, or by changing the profile of gut bacteria, modifying their potential to 
deconjugate and hydrolyse bile acids into secondary bile acids. Both the quantity and relative chemical 
profiles of bile acids returning to the liver will determine the regulatory potential of these important 
cell signaling molecules. Moreover, dietary polyphenols may directly play a cell signaling role by 
modulating transcription factors that regulate important physiological functions, such as intestinal 
permeability, fat absorption, bile acid metabolism, hepatic lipid/cholesterol metabolism, glucose 
homeostasis and systemic inflammation. However, many of the mechanisms that impact on 
physiological processes related to CVD are in animal and in vitro models and remain to be 
convincingly demonstrated in human studies. More suitable powered, randomized, controlled, long 
term, human dietary intervention studies using metagenomic and metabolomic techniques are required 
to progress this research area. 
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